102-48-7

Usage

Uses

Used in Organic Synthesis:
3,4-Dimethylbenzylamine is used as a synthetic intermediate for the production of various organic compounds. Its unique structure allows it to be a key component in the synthesis of a range of molecules, contributing to the diversity of organic chemistry.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 3,4-Dimethylbenzylamine is utilized as a building block for the development of new drugs. Its ability to participate in multiple chemical reactions makes it instrumental in the creation of novel pharmaceutical agents, potentially leading to advancements in medicinal chemistry and drug discovery.
Used in Chemical Reactions:
3,4-Dimethylbenzylamine is used as a reactant in various chemical reactions, such as amination, acylation, and other functional group transformations. Its reactivity and structural features make it a valuable asset in the synthesis of complex organic molecules and the modification of existing compounds to enhance their properties or create new functionalities.

InChI:InChI=1/C9H13N/c1-7-3-4-9(6-10)5-8(7)2/h3-5H,6,10H2,1-2H3

Upstream product

• 22884-95-3 3,4-dimethylbenzonitrile 
• 100-46-9 benzylamine 

Downstream Products

• 25017-35-0 (3,4-Dimethyl-benzyl)-harnstoff 
• 23750-10-9 1,3-bis-(3,4-dimethyl-benzyl)-thiourea 
• 51623-15-5 1-(3,4-dimethyl-benzyl)-3-thiazol-2-yl-thiourea 
• 96275-57-9 N,N',N''-Tris-<3,4-dimethyl-benzyl>-guanidin 
• 132467-26-6 3-(3,4-dimethyl-benzyl)-2-phenyl-thiazolidin-4-one 
• 109932-38-9 3-(3,4-dimethyl-benzyl)-2-(4-methoxy-phenyl)-thiazolidin-4-one 
• 805944-69-8 N-<3,4-Dimethyl-benzyl>-glycin 
• 77314-84-2 [4-(5-Amino-1H-[1,2,4]triazol-3-yl)-pyridin-2-yl]-(3,4-dimethyl-benzyl)-amine 
• 53300-72-4 2-(3,4-dimethyl-benzyl)-3-ethyl-1,4-dioxo-octahydro-pyrrolo[1,2-a]pyrazine-6-carboxylic acid ethyl ester 
• 53300-69-9 estere etilico dell'acido 2-butil-2-(3,4-dimetilbenzil)ottaidro-1,4-diossopirrolo<1,2-a>pirazin-6-carbossilico 
• 908351-69-9 (5-benzyloxycarbonylamino-6-{5-[4-(3,4-dimethyl-benzylcarbamoyl)-benzyl]-[1,2,4]oxadiazol-3-yl}-6-hydroxy-hexyl)-carbamic acid tert-butyl ester 
• 53301-22-7 [3-Butyl-2-(3,4-dimethyl-benzyl)-1,4-dioxo-octahydro-pyrrolo[1,2-a]pyrazin-6-yl]-acetic acid ethyl ester 
• 53300-85-9 3-butyl-2-(3,4-dimethyl-benzyl)-1,4-dioxo-octahydro-pyrrolo[1,2-a]pyrazine-6-carboxylic acid 
• 53300-95-1 [3-butyl-2-(3,4-dimethyl-benzyl)-1,4-dioxo-octahydro-pyrrolo[1,2-a]pyrazin-6-yl]-acetic acid 

Relevant academic research and scientific papers

Versatile Dynamic Covalent Assemblies for Probing π-Stacking and Chirality Induction from Homotopic Faces

Herein we report for the first time the use of dynamic covalent reactions (DCRs) for building a π-stacking model system and further quantifying its substituent effects (SEs), which remain a topic of debate despite the rich history of stacking. A general DCR between 10-methylacridinium ion and primary amines was discovered, in which π-stacking played a stabilizing role. Facile quantification of SEs with in situ competing π-stacking systems was next achieved in the form of amine exchange exhibiting structural diversity by simply varying components. The linear correlation with σm in Hammett plots indicates the dominance of purely electrostatic SEs, and the additivity of SEs is in line with the direct interaction model. With α-chiral amines π-stacking within the adduct enabled chirality transfer from homotopic faces. The strategy of dynamic covalent assembly should be appealing to future research of probing weak interactions and manipulating chirality.